The IHC staining results showed that Ube2L6, SRPX2, and IFIT2 were expressed at higher levels, while CLEC4E, END3, and KIR2DL4 were expressed at lower levels in 25 melanoma specimens (Figure 9). This evidence concerns the gene IFIT2 and melanoma.